VNRX 財務： VolitionRX Ltd AI 分析

首頁

股票

VNRX

VNRX 財務

VolitionRX Ltd

$0.21

-3.19%

$0

收盤價：Feb 18, 16:00:00 GMT-5

$0.21

-0.79%

$0

盤前：Feb 19, 04:46:38 GMT-5

概觀預測收益股利財務狀況

關鍵數據

前收市價

$0.2221

開盤價

$0.22

當日範圍

$0.2013 - $0.2219

52週區間

$0.2111 - $0.94

交易量

1.3M

平均成交量

2.0M

每股盈餘 (TTM)

-0.25

股息收益率

市值

$26.1M

什麼是 VNRX？

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Henderson, Nevada and currently employs 85 full-time employees. The company went IPO on 2015-02-06. The firm is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

功能特性

資源

市場

收入

資產負債表

現金流量

年度

每季

VNRX 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	1	1	0	0	0	0
營收年增率 (YoY)	--	--	--	--	--	--
營收成本	--	--	--	--	--	--
毛利	--	--	--	--	--	--
銷售、一般及管理費用	13	13	16	17	12	6
研發	10	13	18	13	14	13
營業費用	24	28	36	32	28	21
其他非營業收入 (費用)	0	0	0	1	1	0
稅前淨利	-23	-27	-35	-30	-26	-20
所得稅費用	--	--	--	--	--	--
淨利	-23	-26	-35	-30	-26	-20
淨利成長	-28%	-26%	17%	15%	30%	25%
稀釋後流通股數	102.65	86.53	71.23	55.35	52.66	45.28
股數年變動 (YoY)	24%	21%	28.99%	5%	16%	16%
每股盈餘 (稀釋)	-0.24	-0.31	-0.49	-0.55	-0.51	-0.45
每股盈餘成長率	-40%	-37%	-10%	8%	13%	10%
自由現金流	-21	-26	-19	-16	-21	-18
每股自由現金流	--	--	--	--	--	--
毛利率	--	--	--	--	--	--
營業利益率	-2,300%	-2,700%	0%	0%	0%	0%
淨利率	-2,300%	-2,600%	0%	0%	0%	0%
自由現金流利潤率	-2,100%	-2,600%	0%	0%	0%	0%
EBITDA	-22	-26	-34	-31	-28	-21
EBITDA 利潤率	-2,200%	-2,600%	0%	0%	0%	0%
EBITDA 中的折舊與攤銷	1	1	1	0	0	0
EBIT	-23	-27	-35	-31	-28	-21
EBIT 利潤率	-2,300%	-2,700%	0%	0%	0%	0%
有效稅率	--	--	--	--	--	--

VolitionRX Ltd（VNRX）價格

VNRX 股價走勢圖